Biopsychosocial issues in irritable bowel syndrome

Journal of Clinical Gastroenterology

Volumn 39, Issue 8, 2005, Pages 665-669

  Halpert, Albena ^a   Drossman, Douglas ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Functional bowel disorders; Irritable bowel syndrome; Psychosocial factors

Indexed keywords

CENTRAL NERVOUS SYSTEM; HUMAN; HYPERSENSITIVITY; INTESTINE INNERVATION; INTESTINE MOTILITY; IRRITABLE COLON; MODEL; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY;

HUMANS; IRRITABLE BOWEL SYNDROME; MODELS, BIOLOGICAL; MODELS, PSYCHOLOGICAL; PSYCHOPHYSIOLOGY;

EID: 23844488416     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000174024.81096.44     Document Type: Review

References (56)

1. Reading A. Illness and disease. Med Clin North Am. 1977;61:703-706.
2. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129-136.
3. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and health consequences: data and shared mechanisms [Review]. Psychosom Med. 1995; 57:269-274.
4. Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterol. 2001;121:799-804.
5. Walker LS, Greene JW. Children with recurrent abdominal pain and their parents: more somatic complaints, anxiety, and depression than other patient families. J Pediatr Psychol. 1989;14:231-243.
6. Drossman DA, Sandler RS, McKee DC, et al. Bowel patterns among subjects not seeking health care: use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology. 1982;83:529-534.
7. Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology. 1988; 94:1150-1156.
8. Elam M, Thoren P, Svensson TH. Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents. Brain Res. 1986;375:117-125.
9. Mayer EA, Naliboff BD, Chang L, et al. Stress and the gastrointestinal tract v. stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2001;280:G519-G524.
10. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842-848.
11. Bradley LA, Richter JE, Pulliam TJ, et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol. 1993;88:11-19.
12. Kiecolt-Glaser JK, McGuire L, Rubles TF, et al. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom Med. 2002; 64:15-28.
13. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998;42:845-849.
14. Sagami Y, Shimada Y, Tayama J, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut. 2004;53:958-964.
15. Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50:681-689.
16. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy vs. education and desipramine vs. placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19-31.
17. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distension. Gastroenterology. 2000;118:842-848.
18. Derbyshire SW. A systematic review of neuroimaging data during visceral stimulation. Am J Gastroenterol. 2003;98:12-20.
19. Sjolund K, Ekman R, Lindgren S, et al. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome. Scand J Gastroenterol. 1996; 31:1110-1114.
20. Heinrichs SC, Tache Y. Therapeutic potential of CRF receptor antagonists: a gut-brain perspective. Expert Opin Invest Drugs. 2001;10:647-659.
21. Tache Y, Martinez V, Million M, et al. Stress and the gastrointestinal tract: III. Stress-related alterations of gut motor function: role of brain-corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol. 2001;280:G173-G177.
22. Collins SM, Barbara G, Vallance B. Stress, inflammation and the irritable bowel syndrome. Can J Gastroenterol. 1999;13(suppl A):47-49.
23. Drossman DA. Mind over matter in the postinfective irritable bowel. Gut. 1999;44:306-307.
24. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in post- infective gut dysfunction. Gut. 1999;44:400-406.
25. Spiller RC. Post infectious irritable bowel syndrome. Gastroenterology. 2003;124:1662-1671.
26. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfections IBS. Gastroenterology. 2003;125:1651-1659.
27. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997;7083: 779-782.
28. Drossman DA, Talley NJ, Olden KW, et al. Sexual and physical abuse and gastrointestinal illness: review and recommendations. Ann Intern Med. 1995;123:782-794.
29. Creed F. The relationship between psychosocial parameters and outcome in irritable bowel syndrome. Am J Med. 1999;107(suppl):74-80.
30. Creed FH. Life events and physical illness. J Psychosom Res. 1985;29:113-123.
31. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res. 1967;11:213-218.
32. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the life experiences survey. J Consult Clin Psychol. 1978; 46:932-946.
33. Creed FH, Craig T, Fanner RG. Functional abdominal pain, psychiatric illness and life events. Gut. 1988;29:235-242.
34. Drossman DA, Li Z, Leserman J, et al. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology. 1996;110:999-1007.
35. Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci. 1993;38:1581-1589.
36. Ringel Y, Drossman DA, Turkington TG, et al. Regional brain activation in response to rectal distention in patients with irritable bowel syndrome and the effect of a history of abuse. Dig Dis Sci. 2003;48:1774-1781.
37. Taber KH, Rauch SL, Lanius RA, et al. Functional magnetic resonance imaging: application to posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci. 2003;15:125-129.
38. Gray GC, Reed RJ, Kaiser KS, et al. Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol. 2002;155:1033-1044.
39. Ford JD, Campbell KA, Storzbach D, et al. Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom Med. 2001;63:842-849.
40. Dunphy RC, Bridgewater L, Price DD, et al. Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms. Pain. 2003;102:79-85.
41. Drossman DA, Creed FH, Olden KW, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut. 1999;45:II25-II30.
42. Olden KW, Drossman DA. Psychologic and psychiatric aspects of gastrointestinal disease. Adv Gastroenterol. 2000;84:1313-1327.
43. Drossman DA, Chang L. Psychosocial factors in the care of patients with GI disorders. In: Yamada T, ed. Textbook of Gastroenterology. Philadelphia: Lippincott-Raven, 2003:636-654.
44. Bass C, Benjamin S. The management of chronic somatisation. Br J Psychiatry. 1993;80:472-480.
45. Porter M, Gorman D. Approaches to somatisation: issues of time, consultation style, and practice organisation. BMJ. 1989;298:2623-2632.
46. Lazarus RS, Folkman S. Stress, Appraisal and Coping. New York: Springer-Verlag, 1984.
47. Berkman LF. The relationship of social networks and social support to morbidity and mortality. In: Cohen S, Syme SL, eds. Social Support and Health. Orlando, FL: Academic Press, 1985:241-277.
48. Mechanic D. The concept of illness behavior: culture, situation and personal predisposition. Psychol Med. 1986;16:1-7.
49. McHugh S, Vallis TM. Illness Behavior. A Multidisciplinary Model. New York: Plenum Press, 1986.
50. Rosen G, Kleinman A. Social science in the clinic: applied contributions from anthropology to medical teaching and patient care. In: Carr JE, Dengerink HA, eds. Behavioral Science in the Practice of Medicine, 1st ed. New York: Elsevier, 1983:85-103.
51. Lundeen TF, George JM, Toomey TC. Health care system utilization for chronic facial pain. J Craniomandib Disord Facial Oral Pain. 1991;5: 280-285.
52. Maxton DG, Whorwell PJ. Use of medical resources and attitudes to health care of patients with 'chronic abdominal pain.' Br J Med Econ. 1992;2:75-79.
53. Drossman DA, Li Z, Leserman J, et al. Effects of coping on health outcome among female patients with gastrointestinal disorders. Psychosom Med. 2000;62:309-317.
54. Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease specific quality of life questionnaire. Am J Gastroenterology. 2000;95:999-1007.
55. Drossman DA, Whitehead WE, Toner BB, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol. 2000;95:974-980.
56. Drossman DA. What does the future hold for IBS and the functional GI disorders? J Clin Gastroenterol. 2005. (in press).